Terbutaline
Back to searchMolecule Structure
Scientific Name
Terbutaline
Description of the Drug
Terbutaline is a beta-2 adrenergic agonist used as a bronchodilator and to prevent premature labor.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00871
http://www.drugbank.ca/drugs/DB00871
Brand Name(s)
Not Available
Company Owner(s)
Fresenius Kabi Usa Llc, Chartwell Injectables Llc, Hikma Farmaceutica (Portugal) Sa, Novartis Pharmaceuticals Corp, Twi Pharmaceuticals Inc, Pharmacare Ltd, United Biomedical Inc, Ani Pharmaceuticals Inc, Dr Reddys Laboratories Ltd, Lannett Co Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Beta-2 adrenergic receptor | SINGLE PROTEIN | AGONIST | CHEMBL210 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL4391 | |
PharmGKB | PA451616 | |
Human Metabolome Database | HMDB0015009 | |
DrugBank | DB00871 | |
PubChem: Thomson Pharma | 15220540 | |
PubChem | 5403 | |
Mcule | MCULE-3821114202 | |
LINCS | LSM-5065 | |
Nikkaji | J11.466I | |
BindingDB | 25770 | |
EPA CompTox Dashboard | DTXSID7021310 | |
DrugCentral | 2598 | |
ChemicalBook | CB02131227 | |
Guide to Pharmacology | 560 | |
rxnorm | TERBUTALINE SULFATE | TERBUTALINE |
KEGG Ligand | C07129 | |
ChEBI | 9449 |